Erica Holland, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Erica Holland, MD is a sub-specialist in the Division of Maternal and Fetal Medicine. She received her BA from Cornell University and her MD from the University of Massachusetts Medical School. She completed a Residency in Obstetrics and Gynecology from Boston University/Boston Medical Center, a Fellowship in Maternal and Fetal Medicine from Brigham and Women’s Hospital, and a Fellowship in Bioethics from the Center for Bioethics at Harvard Medical School.

She is an attending physician with the multidisciplinary program Project RESPECT, caring for patients with substance use disorder affecting pregnancy and the postpartum period. Her research interests include the role of urine drug testing in pregnancy, the management of opioid use disorder during pregnancy, pain management during and after childbirth, and ethical issues surrounding the care of pregnant individuals.

Dr. Holland is a member of the Boston Medical Center Ethics Committee as well as the ACOG Ethics Committee. She is currently funded by the Greenwall Foundation to study the effects of an ethics-informed policy of urine drug testing on patients and providers. She has been an invited speaker regionally and nationally on the topic of urine drug testing in pregnancy. She aims to apply bioethics theory to dilemmas of clinical obstetrics.

Publications

  • Published 4/22/2025

    Wong ML, Holland E, White KO, Woodhams E. Amniotic fluid embolism in late second trimester abortion: a case report. Eur J Contracept Reprod Health Care. 2025 Jun; 30(3):164-165. PMID: 40261265.

    Read at: PubMed

  • Published 3/1/2025

    Holland E, Joseph NT, Salas-Wright CP, Hacker MR, Hawkins SS. Racial and ethnic differences in self-reported substance use and screening during prenatal care. Am J Obstet Gynecol MFM. 2025 May; 7(5):101660. PMID: 40032180.

    Read at: PubMed

  • Published 8/21/2024

    Wang JZ, Patil V, Landry AP, Gui C, Ajisebutu A, Liu J, Saarela O, Pugh SL, Won M, Patel Z, Yakubov R, Kaloti R, Wilson C, Cohen-Gadol A, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Almiron Bonnin DA, Holland EC, Kruser TJ, Barnholtz-Sloan JS, Sloan AE, Horbinski C, Chotai S, Chambless LB, Gao A, Rebchuk AD, Makarenko S, Yip S, Sahm F, Maas SLN, Tsang DS, Rogers CL, Aldape K, Nassiri F, Zadeh G. Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma. Nat Med. 2024 Nov; 30(11):3173-3183. PMID: 39169220.

    Read at: PubMed

  • Published 8/16/2024

    Brook K, Achu-Lopes RA, Richards JL, Holland E, Langlois WO. In Response. Anesth Analg. 2024 Sep 01; 139(3):e28-e29. PMID: 39151140.

    Read at: PubMed

  • Published 5/23/2024

    Thirimanne HN, Almiron-Bonnin D, Nuechterlein N, Arora S, Jensen M, Parada CA, Qiu C, Szulzewsky F, English CW, Chen WC, Sievers P, Nassiri F, Wang JZ, Klisch TJ, Aldape KD, Patel AJ, Cimino PJ, Zadeh G, Sahm F, Raleigh DR, Shendure J, Ferreira M, Holland EC. Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome. Cell Genom. 2024 Jun 12; 4(6):100566. PMID: 38788713.

    Read at: PubMed

View All 28 Publications:   View Full Profile in BUMC

Websites

Education

  • University of Massachusetts Worcester, MD
  • Cornell University, BA

View all profiles